Evolent Health Announces Second Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Evolent Health (EVH) PT Lowered to $16 at Cantor Fitzgerald
August 7, 2019 9:02 AM EDTCantor Fitzgerald analyst Steven Halper lowered the price target on Evolent Health (NYSE: EVH) to $16.00 (from $18.00) while maintaining a Overweight rating.
... MoreEvolent Health (EVH) Misses Q2 EPS by 3c; Offers Q3 & FY19 Revenues Guidance
August 6, 2019 4:47 PM EDTEvolent Health (NYSE: EVH) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $192.1 million versus the consensus estimate of $192.61 million.
Adjusted Revenue of $192.1 million and $144.5 million for the three months ended June 30, 2019 and 2018, respectively, an increase of 32.9%;Adjusted Services Revenue of $149.7 million and $125.4 million for the three months ended June 30, 2019 and 2018, respectively, before intersegment eliminations of $3.1 million and $3.6 million, respectively; andTrue Health premiums revenue of $45.8 million and $22.9 million for the three months ended June 30, 2019 and 2018, respectively, before intersegment eliminations of $0.3 million and $0.2 million,... More